SUSAN HOLMES: Open Payments
NPI 1396826251 · OPELIKA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 20 payments from 5 companies in 2025. Trend: 2023 $516 · 2024 $552 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $148 |
| Janssen Biotech, Inc. | 8 | $137 |
| Phathom Pharmaceuticals, Inc. | 1 | $123 |
| Aimmune Therapeutics, Inc. | 3 | $64 |
| ABBVIE INC. | 1 | $21 |
Products named: XIFAXAN, TREMFYA, VOQUEZNA, VOWST, ZENPEP, RINVOQ.
Industry payments across AL — which companies pay providers there.
